It's true that the situation is not very good based on the numbers you mentioned. What I said about 2019 was that corporate research and development funding was what put Canada last in the ranking.
I still believe Canada can do better. I was talking about data from 2019, and since then, there has been additional funding in Canada. Initiatives like this need to continue, because—and this gets us back to some extent to the question of patents—for far too long, the only performance indicator used was the number of patent applications.
What we're now seeing in our specific field, the discovery of drugs, is the importance of developing patents and filing high-value patent applications on the composition of products that lead to significant financial gains. It's really a way of proceeding that would raise our profile and increase the value of what we have in Canada.
To get back to your question, I believe that the government really needs to channel its funding and focus on organizations that are working effectively and offering high-value assets that would attract research and development funding from outside the private sector.